TIGER CHINA BIOTECH SOLACTIVETIGER CHINA BIOTECH SOLACTIVETIGER CHINA BIOTECH SOLACTIVE

TIGER CHINA BIOTECH SOLACTIVE

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪33.08 B‬KRW
Fund flows (1Y)
‪−3.09 B‬KRW
Dividend yield (indicated)
Discount/Premium to NAV
−1.02%
Shares outstanding
‪5.64 M‬
Expense ratio
0.49%

About TIGER CHINA BIOTECH SOLACTIVE


Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Tiger ETF
Home page
Inception date
Dec 3, 2020
Index tracked
Solactive China Biotech Index - KRW - Benchmark TR Net
Replication method
Physical
Management style
Passive
Primary advisor
Mirae Asset Global Investments Co., Ltd.
ISIN
KR7371470006
This ETF seeks to replicate the daily performance of the SOLACTIVE China Biotech Index by investing in China,Hong Kong listed equity.or ADR

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of February 12, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks94.68%
Health Technology94.68%
Bonds, Cash & Other5.32%
ETF2.10%
Cash1.88%
Miscellaneous1.35%
Stock breakdown by region
3%96%
Asia96.34%
North America3.66%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows